Tag Archive for: human medicine
PremierNew project started: ‘Prioritisation and risk evaluation of medicines in the environment’ (PREMIER)
The Innovative Medicines Initiative (IMI) project PREMIER aims to develop a centralised, user-friendly digital assessment system accessible for all relevant stakeholders. PREMIER will also explore options to incorporate environment considerations earlier in the drug development process to inform drug design and to reduce the need of animal testing. ECT is involved in this project as […]
Prioritisation and risk evaluation of medicines in the environment (PREMIER)
The Innovative Medicines Initiative (IMI) project ‘Prioritisation and risk evaluation of medicines in the environment’ (PREMIER) aims to develop a centralised, user-friendly and transparent digital assessment system accessible for all relevant stakeholders such as regulatory agencies, pharmaceutical industry, water managers and environmental non-governmental organisations. Furthermore, PREMIER will explore the options to incorporate environment considerations earlier […]
Intelligence-led Assessment of Pharmaceuticals in the Environment (iPiE)
Active pharmaceutical ingredients (APIs) of medicines for human use can be released to the environment during the manufacturing process, following use by patients or when unused medicines are disposed of in an incorrect manner. As APIs are biologically active compounds, concerns have been raised about the potential effects of APIs in the environment on human […]
Environmental risk assessment of pharmaceuticals (ERAPharm)
The widespread detection of a large variety of pharmaceuticals in the environment has raised concerns about the potential impact of these bioactive substances on the environment. Although research on the fate and effects of pharmaceuticals in the environment has become an important issue and progressed significantly, a number of uncertainties remained. Therefore, the overall aim […]